February 7, 2022
A Pandemic Silver Lining: FDA’s New Guidance on Using Digital Health Technologies for Clinical Investigations
December 30, 2021
FDA Issues Draft Guidances on Transitioning Devices from EUAs and Agency Enforcement Policies
August 27, 2021
FDA Rejects Bids To Market CBD-Based Dietary Supplements
August 6, 2021
FDA Finalizes “Intended Use” Regulations
May 5, 2021
Genus Medical Technologies LLC v. FDA: D.C. Circuit Holds FDA Cannot Regulate Devices as Drugs
April 22, 2021
Development of Biosimilar and Interchangeable Biological Products During the COVID-19 Pandemic: What the ANDA Guidance Left Unsaid
March 11, 2021
Biden Administration - What's Ahead for the Life Sciences Industry?
February 5, 2021
FDA Appoints Renowned Cybersecurity Researcher to Head Agency's Medical Device Cybersecurity Efforts
February 2, 2021
USDA Issues Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans
January 4, 2021
FDA Establishes – And HHS Immediately Withdraws – New OTC Drug User Fee Rates
November 30, 2020
Europe – Towards a More Harmonized Market for CBD?
October 26, 2020
France - Trial Period for Medical Use of Cannabis-Based Products